東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Pharmacological interventions for os...

Choi, Andy H.

FindBook

Google Book

Amazon

博客來

Pharmacological interventions for osteoporosis

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Pharmacological interventions for osteoporosis/ edited by Andy H. Choi, Sian Yik Lim.
其他作者:	Choi, Andy H.
出版者:	Singapore :Springer Nature Singapore : : 2023.,
面頁冊數:	x, 118 p. :ill., digital ;24 cm.
內容註:	Bisphosphonates and Osteonecrosis of the jaw -- Denosumab: Clinical Applications and Outcomes -- Romosozumab: Clinical Outcomes and Outcomes -- Abaloparatide: Clinical Outcomes and its Effects in Bone Regeneration -- Teriparatide: Clinical Outcomes and its Effects in Bone Regeneration.
Contained By:	Springer Nature eBook
標題:	Osteoporosis - Chemotherapy. -
電子資源:	https://doi.org/10.1007/978-981-99-5826-9
ISBN:	9789819958269

Pharmacological interventions for osteoporosis
Pharmacological interventions for osteoporosis[electronic resource] /edited by Andy H. Choi, Sian Yik Lim. - Singapore :Springer Nature Singapore :2023. - x, 118 p. :ill., digital ;24 cm. - Tissue repair and reconstruction,2731-9199. - Tissue repair and reconstruction..

Bisphosphonates and Osteonecrosis of the jaw -- Denosumab: Clinical Applications and Outcomes -- Romosozumab: Clinical Outcomes and Outcomes -- Abaloparatide: Clinical Outcomes and its Effects in Bone Regeneration -- Teriparatide: Clinical Outcomes and its Effects in Bone Regeneration.

This book provides readers a fundamental insight into the basic properties of the pharmaceutical agents used in the treatment of osteoporosis. It provides insight into mechanisms of action, updated information on clinical utility, and possible side effects associated with the use of these pharmaceutical agents. In particular, it highlights the use of two monoclonal antibodies romosozumab and denosumab in activating osteoblast differentiation and inhibiting osteoclasts. It also discusses two anabolic pharmaceutical agents, teriparatide and abaloparatide to treat osteoporosis. They have been shown to reduce the incidence of non-vertebral and vertebral fractures significantly after they were administered to patients daily as subcutaneous injections. The content of this book caters to researchers, scientists, and clinical practitioners who are interested in the treatment of osteoporosis using pharmaceutical agents.

ISBN: 9789819958269

Standard No.: 10.1007/978-981-99-5826-9doiSubjects--Topical Terms:

3666796
Osteoporosis
--Chemotherapy.

LC Class. No.: RC931.O73

Dewey Class. No.: 616.713061

Pharmacological interventions for osteoporosis
LDR:02246nmm a2200337 a 4500 001 2334847
003 DE-He213
005 20230921200813.0
006 m d
007 cr nn 008maaau
008 240402s2023 si s 0 eng d
020 $a 9789819958269 $q (electronic bk.)
020 $a 9789819958252 $q (paper)
024 7 $a 10.1007/978-981-99-5826-9 $2 doi
035 $a 978-981-99-5826-9
040 $a GP $c GP
041 0 $a eng
050 4 $a RC931.O73
072 7 $a MQW $2 bicssc
072 7 $a TEC059000 $2 bisacsh
072 7 $a MQW $2 thema
082 0 4 $a 616.713061 $2 23
090 $a RC931.O73 $b P536 2023
245 1 0 $a Pharmacological interventions for osteoporosis $h [electronic resource] / $c edited by Andy H. Choi, Sian Yik Lim.
260 $a Singapore : $b Springer Nature Singapore : $b Imprint: Springer, $c 2023.
300 $a x, 118 p. : $b ill., digital ; $c 24 cm.
490 1 $a Tissue repair and reconstruction, $x 2731-9199
505 0 $a Bisphosphonates and Osteonecrosis of the jaw -- Denosumab: Clinical Applications and Outcomes -- Romosozumab: Clinical Outcomes and Outcomes -- Abaloparatide: Clinical Outcomes and its Effects in Bone Regeneration -- Teriparatide: Clinical Outcomes and its Effects in Bone Regeneration.
520 $a This book provides readers a fundamental insight into the basic properties of the pharmaceutical agents used in the treatment of osteoporosis. It provides insight into mechanisms of action, updated information on clinical utility, and possible side effects associated with the use of these pharmaceutical agents. In particular, it highlights the use of two monoclonal antibodies romosozumab and denosumab in activating osteoblast differentiation and inhibiting osteoclasts. It also discusses two anabolic pharmaceutical agents, teriparatide and abaloparatide to treat osteoporosis. They have been shown to reduce the incidence of non-vertebral and vertebral fractures significantly after they were administered to patients daily as subcutaneous injections. The content of this book caters to researchers, scientists, and clinical practitioners who are interested in the treatment of osteoporosis using pharmaceutical agents.
650 0 $a Osteoporosis $x Chemotherapy. $3 3666796
650 1 4 $a Biomedical Engineering and Bioengineering. $3 3381533
650 2 4 $a Regenerative Medicine and Tissue Engineering. $3 3538451
650 2 4 $a Medicinal Chemistry. $3 892420
700 1 $a Choi, Andy H. $3 3591837
700 1 $a Lim, Sian Yik. $3 3666795
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
830 0 $a Tissue repair and reconstruction. $3 3633979
856 4 0 $u https://doi.org/10.1007/978-981-99-5826-9
950 $a Medicine (SpringerNature-11650)